Company: ELV
Filing Date: 2025-07-17
Form Type: 10-Q
Source: 0001156039-25-000114
Chunk: 40

Company: Elevance Health, Inc.
Filing Date: 2025-07-17
Form: 10-Q
Item: Item 8
Chunk 40
---
 no significant concentrations of financial instruments in a single investee, industry or geographic location.

`12.     Capital Stock 

Stock Incentive PlansA summary of stock option activity for the six months ended June 30, 2025 is as follows:Number ofSharesWeighted-AverageOption Priceper ShareWeighted-AverageRemainingContractualLife (Years)AggregateIntrinsicValueOutstanding at January 1, 20252.9 $361.36 Granted0.6 395.79 Exercised(0.2)217.35 Outstanding at June 30, 20253.3 372.63 6.00$169 Exercisable at June 30, 20252.2 341.60 4.66$169 A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the six months ended June 30, 2025 is as follows:RestrictedStock Sharesand UnitsWeighted-AverageGrant DateFair Valueper ShareNonvested at January 1, 20251.0 $478.70 Granted0.6 395.28 Vested(0.4)467.06 Forfeited(0.1)454.44 Nonvested at June 30, 20251.1 440.25 During the six months ended June 30, 2025, we granted approximately 0.2 restricted stock units that are contingent upon us achieving earnings targets over the three-year period from 2025 to 2027. These grants have been included in the activity shown above but will be subject to adjustment at the end of 2027 based on results during the three-year period.Fair ValueWe use a binomial lattice valuation model to estimate the fair value of all stock options granted. For a more detailed discussion of our stock incentive plan fair value methodology, see Note 15, “Capital Stock,” to our audited consolidated financial statements as of and for the year ended December 31, 2024 included in Part II, Item 8 of our 2024 Annual Report on Form 10-K. 

-29-

The following weighted-average assumptions were used to estimate the fair values of options granted during the six months ended June 30, 2025 and 2024:Six Months Ended June 3020252024Risk-free interest rate4.29 %4.28